Eradication of detectable minimal residual disease (MRD) in CLL is associated with improved progression-free and overall survival. Herewe present the first multivariate analysis from 137 responding CLLpatients treated between 1996 and 2007 with bone marrow MRD assessment by multicolour flow cytometry (sensitivity: 1 CLL cell in10,000 leukocytes [HMDS]).
|Title of host publication||British Journal of Haematology|
|Number of pages||21|
|Publication status||Published - 2010|
|Name||British Journal of Haematology|